Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Review article: pharmacotherapy for alcohol dependence – the why, the what and the wherefore
ET Goh, Marsha Y. Morgan
Alimentary Pharmacology & Therapeutics (2017) Vol. 45, Iss. 7, pp. 865-882
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Evidence-Based Guidelines and Secondary Meta-Analysis for the Use of Transcranial Direct Current Stimulation in Neurological and Psychiatric Disorders
Felipe Fregni, Mirret M. El-Hagrassy, Kevin Pacheco‐Barrios, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 24, Iss. 4, pp. 256-313
Open Access | Times Cited: 426
Impact of Alcohol Use Disorder Treatment on Clinical Outcomes Among Patients With Cirrhosis
Shari S. Rogal, Ada O. Youk, Hongwei Zhang, et al.
Hepatology (2019) Vol. 71, Iss. 6, pp. 2080-2092
Open Access | Times Cited: 160
Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta‐analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate
Clément Palpacuer, Renan Duprez, Alexandre Huneau, et al.
Addiction (2017) Vol. 113, Iss. 2, pp. 220-237
Open Access | Times Cited: 142
Neurobiological correlates of cue-reactivity in alcohol-use disorders: A voxel-wise meta-analysis of fMRI studies
Jianguang Zeng, Shuxian Yu, Hengyi Cao, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 128, pp. 294-310
Closed Access | Times Cited: 70
Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study
Victoria Hamill, Stanley Wong, Jennifer Benselin, et al.
BMJ (2023), pp. e074001-e074001
Open Access | Times Cited: 21
Advances in the understanding and management of alcohol-related liver disease
Mark Thursz, Anne Lingford‐Hughes
BMJ (2023), pp. e077090-e077090
Closed Access | Times Cited: 16
Diagnosis and Treatment of Alcohol Use Disorder in Patients With End‐Stage Alcoholic Liver Disease
Fabio Caputo, Marco Domenicali, Mauro Bernardi
Hepatology (2018) Vol. 70, Iss. 1, pp. 410-417
Closed Access | Times Cited: 46
Understanding the neurobiological effects of drug abuse: Lessons from zebrafish models
Talise E. Müller, Bárbara D. Fontana, Kanandra Taisa Bertoncello, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 100, pp. 109873-109873
Open Access | Times Cited: 38
The influence of anxiety symptoms on clinical outcomes during baclofen treatment of alcohol use disorder: A systematic review and meta-analysis
Roberta Agabio, David S. Baldwin, Hugo Amaro, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 125, pp. 296-313
Open Access | Times Cited: 27
Exploring views and experiences of a unique alcohol assertive outreach model, the primary care alcohol nurse outreach service (PCANOS): a qualitative study
Clare Sharp, Andrea Mohan, Danielle Mitchell, et al.
BMC Primary Care (2025) Vol. 26, Iss. 1
Open Access
Alcohol addiction - the safety of available approved treatment options
Massimo Antonelli, Anna Ferrulli, Luisa Sestito, et al.
Expert Opinion on Drug Safety (2017) Vol. 17, Iss. 2, pp. 169-177
Closed Access | Times Cited: 39
Real‐world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation‐wide cohort of 125 556 patients
Milja Heikkinen, Heidi Taipale, Antti Tanskanen, et al.
Addiction (2021) Vol. 116, Iss. 8, pp. 1990-1998
Open Access | Times Cited: 26
rTMS Reduces Craving and Alcohol Use in Patients with Alcohol Use Disorder: Results of a Randomized, Sham-Controlled Clinical Trial
Maarten Belgers, Philip van Eijndhoven, Wiebren Markus, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 951-951
Open Access | Times Cited: 17
Alcohol-associated liver disease: Emerging therapeutic strategies
Benjamin H. Mullish, Mark Thursz
Hepatology (2024) Vol. 80, Iss. 6, pp. 1372-1389
Closed Access | Times Cited: 3
Pharmacological treatments for opiate and alcohol addiction: A historical perspective of the last 50 years
M. Carmen Blanco-Gandía, Marta Rodríguez‐Arias
European Journal of Pharmacology (2018) Vol. 836, pp. 89-101
Closed Access | Times Cited: 28
Diagnosis and Management of Alcohol Use Disorder in Patients with Liver Disease: Lights and Shadows
Giovanni Addolorato, Gabriele Vassallo, Antonio Mirijello, et al.
Neurotherapeutics (2019) Vol. 17, Iss. 1, pp. 127-141
Open Access | Times Cited: 25
Management of end-stage alcohol-related liver disease and severe acute alcohol-related hepatitis: position paper of the Italian Society on Alcohol (SIA)
Gianni Testino, Teo Vignoli, Valentino Patussi, et al.
Digestive and Liver Disease (2019) Vol. 52, Iss. 1, pp. 21-32
Closed Access | Times Cited: 25
Baclofen in the Treatment of Patients With Alcohol Use Disorder and Other Mental Health Disorders
Roberta Agabio, Lorenzo Leggio
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 24
Survey of Addiction Specialists’ Use of Medications to Treat Alcohol Use Disorder
Jarrod Ehrie, Emily E. Hartwell, Paige E. Morris, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 21
Pharmacology, Systematic Review and Recent Clinical Trials of Metadoxine
Mathieu Di Miceli, B. Gronier
Reviews on Recent Clinical Trials (2018) Vol. 13, Iss. 2, pp. 114-125
Open Access | Times Cited: 21
Treating Alcohol Use Disorder in Patients with Alcohol-Associated Liver Disease: Controversies in Pharmacological Therapy
Claudia Tarli, Antonio Mirijello, Giovanni Addolorato
Seminars in Liver Disease (2022) Vol. 42, Iss. 02, pp. 138-150
Closed Access | Times Cited: 11
Alcoholism and nutrition: a review of vitamin supplementation and treatment
Michael J. Lewis
Current Opinion in Clinical Nutrition & Metabolic Care (2020) Vol. 23, Iss. 2, pp. 138-144
Closed Access | Times Cited: 16
First-line Medications for the Outpatient Treatment of Alcohol Use Disorder: A Systematic Review of Perceived Barriers
Caroline Gregory, Yelena Chorny, Shelley McLeod, et al.
Journal of Addiction Medicine (2021) Vol. 16, Iss. 4, pp. e210-e218
Closed Access | Times Cited: 15
Exploring the role of low-frequency and rare exonic variants in alcohol and tobacco use
Andries T. Marees, Anke R. Hammerschlag, Lisa Bastarache, et al.
Drug and Alcohol Dependence (2018) Vol. 188, pp. 94-101
Open Access | Times Cited: 15
Selecting an appropriate alcohol pharmacotherapy
Sari Castrén, Niklas Mäkelä, Hannu Alho
Current Opinion in Psychiatry (2019) Vol. 32, Iss. 4, pp. 266-274
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top